A Glossary of Terms in Thrombocardiology
Abciximab Monoclonal antibody fragment inhibitor of the platelet glycoprotein IIb/IIIa receptor complex. Over a series of randomized clinical trials (EPIC, EPILOG, CAPTURE), it demonstrated its effectiveness in reducing ischemic complications of percutaneous coronary intervention. It is the first agent of its class approved for use in the setting of high-risk coronary angioplasty by the U.S. Food and Drug Administration.
KeywordsPercutaneous Coronary Intervention Acute Myocardial Infarction Thrombin Generation Thrombolytic Agent Tissue Factor Pathway Inhibitor
Unable to display preview. Download preview PDF.